Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011425:Propionibacterium acnes / Q000276:immunology*
D001428:Bacterial Vaccines